MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
8.50%
Quick Ratio
5.79%
Cash Ratio
1.52%
Debt to Asset Ratio
462.97%
Unit: Thousand (K) dollars
Assets Breakdown
    • Investment in convertible bond
    • Accounts receivable, net
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Accounts payable and accrued exp...
    • Others
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
1,072
2,127
293
886
Accounts receivable, net
2,048
2,804
2,619
2,071
Inventories, net
1,909
1,555
1,213
1,313
Prepaid expenses and other current assets
966
1,260
661
745
Total current assets
5,995
7,746
4,786
5,015
Property and equipment, net
98
113
128
143
Right of use assets
736
766
799
830
Investment in convertible bond
11,664
12,604
14,876
17,188
Other assets
203
207
167
168
Total assets
18,696
21,436
20,756
23,344
Accounts payable and accrued expenses
24,487
22,615
21,759
19,373
Operating lease liabilities, current portion
349
348
348
348
Conversion feature derivative, notes payable
235
0
-
-
Other current liabilities
17,443
17,565
14,475
14,139
Warrant derivative liabilities
15
13
11
13
Notes payable to related parties-Nonrelated Party
7,529
8,019
7,640
8,267
Notes payable to related parties-Related Party
3,123
3,132
3,132
3,132
Convertible notes payable, net of discount
17,356
17,380
16,804
16,804
Total current liabilities
70,537
69,072
64,169
62,076
Operating lease liabilities, less current portion
1,324
1,409
1,498
1,584
Other long-term liabilities
12,418
12,292
12,313
13,128
Notes payable to related parties, net of discount
2,277
2,271
2,264
2,257
Total liabilities
86,556
85,044
80,244
79,045
Common stock, par value 0.001 per share, 250,000,000 shares authorized, 70,188,263 shares issued and outstanding at march 31, 2026 2026 and december 31, 2025, respectively
70
70
64
64
Additional paid-in capital
225,988
225,987
225,914
225,905
Net loan receivable from ej holdings
16,869
16,869
16,869
16,869
Accumulated other comprehensive loss
-3,647
-2,729
-481
1,239
Accumulated deficit
-273,402
-270,067
-268,116
-266,040
Total stockholders deficit
-67,860
-63,608
-59,488
-55,701
Total liabilities and stockholders' deficit
18,696
21,436
20,756
23,344
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Accounts receivable, net$2,048K Inventories, net$1,909K Cash and cashequivalents$1,072K Prepaid expenses andother current assets$966K Investment in convertiblebond$11,664K Total current assets$5,995K Right of use assets$736K Other assets$203K Property and equipment,net$98K Total assets$18,696K Accumulated deficit-$273,402K Net loan receivablefrom ej holdings$16,869K Accumulated othercomprehensive loss-$3,647K Total liabilities andstockholders' deficit$18,696K Total stockholdersdeficit-$67,860K Additional paid-in capital$225,988K Common stock, par value0.001 per share,...$70K Total liabilities$86,556K Total currentliabilities$70,537K Other long-termliabilities$12,418K Notes payable torelated parties, net of...$2,277K Operating leaseliabilities, less current...$1,324K Accounts payable andaccrued expenses$24,487K Other currentliabilities$17,443K Convertible notes payable,net of discount$17,356K Notes payable torelated...$7,529K Notes payable torelated...$3,123K Operating leaseliabilities, current portion$349K Conversion featurederivative, notes payable$235K Warrant derivativeliabilities$15K

Emmaus Life Sciences, Inc. (EMMA)

Emmaus Life Sciences, Inc. (EMMA)